Sound Point Meridian Capital, Inc.

Thank you. Ladies and gentlemen, this is the operator. Today's conference is scheduled to begin in two minutes. Until that time, your lines will remain on music hold. Thank you. Thank you. Good morning, ladies and gentlemen, and welcome to the SoundPoint Meridian Capital Inc. Fourth Fiscal Quarter ended March 31, 2025 Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, May 29th of 2025. I would now like to turn the conference over to Julie Smith, Head of Investor Relations. Please go ahead.

Ladies and gentlemen, thank you for standing by. Sound Point Meridian Capital refers participants on this call to the investor webpage at www.soundpointmeridiancap.com for the press release, investor information, and filings with the Securities and Exchange Commission, and for a discussion of the risks that can affect the business. Sound Point Meridian Capital specifically refers participants to the presentation furnished today on the Form 8K with the SEC, and to remind listeners that some of the comments today may contain forward-looking statements and, as such, will be subject to risks and uncertainties which, if they materialize, could materially affect results. References made to the section titled Forward-Looking Statements in the Company's Earnings Press Release for the period ended March 31, 2025, which is incorporated herein by reference. We note forward-looking statements, whether written or oral, include, but are not limited to, SoundPoint Meridian Capital's expectation or prediction of financial and business performance and conditions, as well as its competitive and industry outlook. Forward-looking statements are subject to risks, uncertainties, and assumptions which, if they materialize, could materially affect results. And such forward-looking statements do not guarantee performance, and SoundPoint Meridian Capital gives no such assurances. SoundPoint Meridian Capital is under no obligation and expressly disclaims any obligation to update, alter, or otherwise revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. In addition, historical data pertaining to the operating results and other performance indicators applicable to Sound Point Meridian Capital are not necessarily indicative of results to be achieved in succeeding periods. I will now turn the call over to Ujjval Desai, Chief Executive Officer of Sound Point Meridian Capital.

Thank you to everyone joining us today, and welcome to the SoundPoint Meridian Capital earnings call for the fiscal fourth quarter ended March 31st, 2025. We'd like to invite you to download our investor presentation from our website, which provides additional information about the company and our portfolio. With me today is our Chief Financial Officer, Kevin Gerlitz, and after our prepared remarks, we will open it up to your questions. We are happy to report our results for the fourth fiscal quarter as well as summary highlights for SPMC's first year of operations. For the quarter, we generated net investment income, or NII, of $13.4 million, or 66 cents per share, and net realized loss on exited investments of 8 cents per common share, while we paid dividends during the quarter of 72 cents per share. Net asset value per share ended the quarter at $18.78, down from where it stood on December 31st at $20.52, driven mainly by unrealized losses in the portfolio as a result of uncertainty surrounding the new administration's tariff rollout and reduction in government spending. During the quarter, we deployed approximately $70.6 million in six CLO warehouse investments. We purchased four CLO equity investments in the primary market with an amortized cost and weighted average gap yield of $60.9 million and 16.15% respectively. We refinanced the liabilities of three CLO equity investments in the portfolio and had one outstanding warehouse investment as of March 31st with one unfunded commitment to purchase CLO equity with a cost of $12.3 million. For the year ended March 31st, 2025, we deployed $291.8 million into CLO equity investments across 17 new issue transactions 19 refinancing transactions, and eight secondary market purchases. Additionally, we participated in 18 CLO warehouses. We recorded NII of $2.22 per share compared to distributions of $2.08 per share. As of March 31st, the weighted average gap yield on our CLO equity portfolio was 14.0% versus 15.2% as of December 31st. The decrease in gap yield was mainly the result of loan repricings in the underlying CLO portfolios, which reduced estimated future cash flows available to CLO equity holders. This was slightly offset by CLO refinancing and reshare activity, which lowered the CLO liability costs on certain CLO investments in the portfolio. Our portfolio as of March 31st was diversified across 75 CLO investments managed by 23 CLO managers. The underlying loan portfolio consisted of over 1,500 loan issuers across 30-plus industries on a look-through basis. We believe this strategy of broad diversification enables us to manage risk effectively, providing us with dividend sustainability and downside protection through changing market conditions. Turning to the right side of our balance sheet, during our first year of operations, we entered into a two-year, $100 million revolving credit facility at a floating financing rate of SOFR plus 375, providing us with the flexibility to patiently deploy capital in attractive investment opportunities over time. Additionally, we issued a five-year, $57.5 million Series A preferred offering with an 8% stated rate, resulting in net proceeds of $55.7 million. On March 14, 2025, the company commenced a committed equity financing agreement with B. Reilly Principal Capital II, LLC. Under this agreement, the company has the right, but not the obligation, to direct B. Riley to purchase up to roughly 4 million shares of common stock over a 36-month period. As of March 31st, B. Riley purchased approximately 5,700 shares, resulting in about $113,000 of net proceeds to the company. Subsequent to quarter end, as of April 30th, 2025, our estimated net asset value per common share was $17.55. On May 29th, we announced monthly distributions for calendar Q3 2025 of 25 cents per share, unchanged from our previously announced Q2 2025 monthly distributions. With that, I'll now turn the call over to Kevin for a more detailed review of our financial highlights for the quarter.

Thank you, Ujabal, and hello, everyone. As Ujabal mentioned, the quarter ended March 31st, 2025, we delivered net investment income of $13.4 million or 66 cents per share. When the quarter ended March 31st, we recorded net realized losses of $1.7 million and unrealized losses on investments of $32.3 million. Total expenses for the period ended March 31st for $9.3 million. Gap net income loss for the quarter was $20.7 million or a loss of a dollar two per share moving to our balance sheet as of march 31st total assets were 514.1 million dollars net assets were 381.6 million dollars and our net asset value stood at 18.78 cents per share the fair value of our investment portfolio stood at 503.7 million dollars while available liquidity consisting of cash was approximately 9.9 million dollars at the end of the quarter. As of March 31st, the company had outstanding debt that totaled 24.5% of total assets. During the quarter, we declared monthly income distributions of 25 cents per share, payable at the end of April, May, and June. Based on our share price as of March 31st, this represents an annualized dividend yield of 15%. Overall, we are pleased with our strong results this quarter and believe we are well-positioned to sustain our momentum going forward. I will now turn it back to our CEO, Ujjavalt Desai.

Thanks, Kevin. Before opening up for questions, I want to give a quick update on the overall market environment for corporate loans and CLO activity. At the beginning of 2025, repricing activity continued in the corporate loan market, while CLO liability spreads approached record tight levels. The CLO machine continued firing on all cylinders in January and early February 2025, coming off a record year of new issuance in 2024. As we approach March, tariffs and geopolitical headlines dominated the CLO market, and the resulting market uncertainty effectively froze CLO new issue activity. Through March 31st, the Morningstar LSTA US leveraged loan index returned 48 basis points, which was the weakest quarterly performance since Q2 2022. Loans kicked off 2025 on a strong note, reaching their recent tights by the end of January, as the market continued to experience spread compression driven by repricings. Market uncertainty shifted investor sentiment in February and March, resulting in a secondary sell-off in the loan market. For context, 66% of the loan market was priced at par or higher in January, but by the end of March, this had fallen to just 10%. This dynamic has brought about a reprieve from further spread compression within the loan asset class, as the heavy amount of repricing finally came to an end in March. Turning to the CLO market, demand for newly issued CLOs remained strong in the first quarter, with CLO creations reaching 153 billion through March 31st, the second largest quarterly activity in CLO 2.0 history. Elevated issuance was primarily driven by the rally in CLO debt spreads to 2.0 tides, fueling a wave of recess and refinancing from January and February, which accounted for approximately 70% of new issue activity. Tariff-induced volatility subsequently widened CLO spreads in March, effectively pausing reset and refinancing activity. On the asset side of the equation, the reprieve from repricings in the loan market, along with the price drop described above, has improved the difference between the spread on debt tranches and where CLO managers can buy loans. This difference is commonly referred to as a CLO's arbitrage and benefits CLO equity as it increases. Given our portfolio's tilt to recently issued CLOs, we believe that we are well-positioned to benefit from continued volatility as top-tier active CLO managers have the ability to take advantage of relative value trading opportunities in the loan market. Looking ahead, with the expectation for continued volatility under an uncertain tariff regime, we believe our portfolio is defensively positioned in investments with longer reinvestment periods. allowing CLO managers to actively manage the underlying loan portfolios to avoid defaults and buy loans at discounted prices. With our focus on newer CLO investments, we also believe that our CLO equity investments will continue to make strong quarterly cash flow distributions, allowing us to continue paying monthly distributions to our common shareholders. With that, we thank you for your time and would like to open up the call for Q&A. Operator?

Thank you. Ladies and gentlemen, we will now conduct the question and answer session. If you would like to ask the question, press Start and the number one on your telephone keypad. If you would like to withdraw your question, please press Start too. If you're using a speakerphone, please leave the handset before pressing any keys. One moment please for your first question. Our first question comes from the line of Eric Zwick from Lucid Capital Markets. Your line is open.

Thank you. Good morning, everyone. Wanted to start just with a question, you know, mentioned in your prepared remarks that loan repricing is likely finished in the near term. Curious about the opportunity, I guess kind of more on the liability side and, you know, opportunity for refis and resets that remain in your portfolio today.

Sure, Eric. Thanks for the question. So yes, you're right. The reset, the repricings on the loan side has paused for now. The liability side, the activity was also pretty slow in kind of March, April of this year, given the volatility. What we're seeing now, liability spreads tightening back again. If you look at AAAs, for instance, sort of tier one AAAs, which were which reached about 110, 115 basis points or so far in February. Those widened out to call it 150 in April, and now AAAs are back to 130 area for Tier 1. So we have seen spreads compressed not all the way back to the tides we saw earlier, but getting there. And so we think that the reset activity is going to start up again, and that will help reduce costs of debt in our portfolios. We have quite a few positions in our funds that were issued in 23 and 24, which will be up for a reset this year and early next year. And so we expect to take advantage of that. And that should certainly be very helpful to our portfolio.

That's helpful. And you have a fair amount of liquidity available to you at this point, as you noted, just due to the revolver and some recent capital you've raised. So curious as you look at the opportunities for deployment today, and you kind of mentioned the theme that given that you've got a number of newer issues, you have the opportunity to take advantage of market volatility. So I'm reading that as maybe you're seeing some attractive opportunities in the secondary market to get some CLO securities that you deem are You have very attractive risk adjusted possible returns. So just curious, kind of as you frame deployment opportunities between primary and secondary today.

Yes. So I think there is sort of a couple of points I want to mention there. One is we have been very focused on trading our portfolio, reacting to the market. So earlier this year in Jan and Feb, We actually sold a bunch of positions in our portfolio at very tight levels where we thought the market was not pricing risk correctly. And that allowed us to generate cash in our funds. In the case of Meridian, we didn't have to draw on the facility as much. And so we kept that sort of 30 million or so off the facility undrawn. So we kind of delevered the fund, if you will. And then since the end of the quarter, so in kind of end of April and most of May, we have been adding risk in the portfolio. We've been able to find a lot of very interesting secondary investments as well as some primary investments as well. So that's kind of our overall approach to managing these portfolios is to kind of take risk on and off depending on market opportunities. We certainly do like the market conditions. Secondary is active. Primary is also open now, but it's a little bit harder to execute primary deals because the liabilities and loan spreads prices have moved so fast over the last few weeks that you got to time it correctly. So we are cautiously involved in a bunch of new issue transactions as well.

That's great color. Thank you. looking at the unrealized losses in the most recent quarter curious if you could you know provide a little commentary in terms of you know how much was just market related moving to to loan prices dropping versus maybe company specific fundamentals that um may have had some changes and um i suspect it's more of the former which hopefully is is more of a temporary nature but just curious to hear your thoughts there yeah absolutely great question there

So there were two factors that created this unrealized loss. One was, as you mentioned earlier, the spread compression in the underlying loan portfolios through refinancing. And so obviously whenever the underlying portfolio has lower spread going forward, that means equity cash flows are going to be lower. So that reduces cash flows coming in. and you've seen our gap yields become tighter with the rest of the market. So that was one thing. The second thing that happened was because of general market vol, CLA Equity was trading at wider yields, so the cash flows were getting discounted at higher discount rates. So that was, again, purely technical. We haven't seen any material increase in defaults or stress in our portfolios that we have in Meridian. So we feel that most of the drop we have seen is because of general market volatility. And certainly we expect that to recover. And we've already seen market sentiment improve significantly in May, so we hope to capture a lot of that back fairly soon.

Great. And one last question, just kind of a record-keeping note. I noticed in the press release and presentation you indicated for the month of April a figure for recurring cash flows. Do you have that figure for the three months ended March 31st? I may have missed it, but didn't see that.

Yes, so Josh, go ahead.

Yeah, sorry, that's a 21 million of cash we received for. In April.

You're asking about the quarter or for April?

Yes, yes, I saw the April figure. I didn't see a similar figure for the three months. for the quarter that ended March 31st. I don't know if you had that number on hand as well.

Yeah, we'll grab that. I'll come back to you. We're just pulling it up. Okay, great. Thank you. That's all I had today.

I appreciate it.

Sure. Again, if you would like to ask a question, please press star then the number one on your telephone keypad. Our next question comes from the line of Randy Piner from BU Biosecurities. Your line is open.

Hi. Thank you for taking the question. This is Tim D'Agostino on for Randy Piner. It looks like the portfolio is underweight healthcare relative to peers. Do you have any view on changes to HHS and or CMS funding? Thank you.

Hi there. Thanks for the question. Yeah, I mean, look, that is a very specific question that impacts individual companies. We're not taking a view necessarily at this stage on, you know, being underrated healthcare or over healthcare. You know, we are selecting managers that are taking that view themselves. And I think it comes down to really, you know, name by name sort of idiosyncratic analysis that you have to do in terms of the impact of cuts to healthcare, kind of funding, you know, Doge cuts and all that. So I think it's more of a name by name analysis. And then on that basis, kind of that then gets reflected into portfolio construction at the CLO level and then at our fund level. So we're not taking a particular view on that right now. I think, you know, what we are more focused on from our perspective is looking at sort of where loans are trading in each sector and kind of these risks are already factored into the loan prices and we're tracking that to see how much sort of stressed exposure we have in our portfolios and whether we want to adjust that, risk manage that or not.

Okay, thank you so much. And then another quick question. Was there any issuance of common or preferred shares in the quarter? Thank you.

Not in Q1. There was no issuance of uh the uh the preferred um we obviously have the the b riley facility um which we uh we had a small i think i mentioned 113 000 was raised in uh march because that facility started in early march and so we only had a couple of weeks of that facility okay thank you so much that's all for it yeah uh great thank you for the question and uh just going back to um the question from eric on uh the free cash flow for the for the quarter yeah for quarter ending march 31st it was 16.6 million that's the full quarter okay 16.6 million there are no further questions at this time please continue Okay, great. Well, thank you very much again for attending the call and your support for SPMC, and we look forward to talk to everyone next quarter. Thank you. Bye-bye.

This concludes today's conference call. You may disconnect the lines.